App aims to ease chemo side effects in breast cancer patients
NCT ID NCT05425550
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tested a digital health app called medidux™ to see if it could help track and reduce serious side effects in people with HER2-positive breast cancer undergoing chemotherapy and targeted therapy. The trial planned to enroll 196 adults but was terminated early. The main goal was to count severe side effects over 12 to 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Seespital Horgen-Onkologie
Horgen, 8810, Switzerland
Conditions
Explore the condition pages connected to this study.